arXiv subjects

Ashkan Ghorbani

Publications and source records attributed to Ashkan Ghorbani.

2 recordsLinked to original sources

arXiv2026

From Density to Biopsy Decisions and Malignancy Prediction: A Benchmark Study of Multimodal Large Language Models Against Radiologists in Digital and Contrast-Enhanced Mammography

Purpose: To compare four multimodal large language models (MLLMs) with radiologists of varying expertise in breast density assessment, BI-RADS assessment, biopsy candidacy determination, and continuous malignancy probability estimation using digital mammography (DM) and contrast-enhanced mammography (CEM). Methods: This study included 179 women with paired DM/CEM examinations and reference standards. Four MLLMs (ChatGPT-5.2, Gemini-3.1 Pro, Sonnet-4.6, Muse Spark) interpreted images with and without masks; three radiologists interpreted non-masked images. Results: For binary density classification on DM, radiologist accuracies ranged from 55.81% to 78.60%, exceeding most MLLM values (62.33%-71.63%), while masks added limited benefit. Five-category BI-RADS accuracies were higher for radiologists on DM (56.74-67.44%) and CEM (62.33-82.79%) compared with MLLMs (DM 31.16-45.12%; CEM 40.00-55.81%). Binary biopsy-candidacy accuracies were likewise higher for radiologists (DM 85.12-89.77%; CEM 86.98-92.09%) than for MLLMs (DM 61.39-75.35%; CEM 69.30-82.79%), although CEM improved performance across all readers. Lesion masks substantially improved MLLM continuous malignancy-probability accuracies from 64.65%-71.63% to 72.56-78.60% on DM and from 67.91%-77.21% to 72.56%-81.86% on CEM, approaching radiologist ranges (DM 63.72-82.79%; CEM 81.86-88.84%). The corresponding AUCs for the top masked models overlapped those of the human readers. Overall, Muse Spark, followed by Sonnet-4.6, demonstrated the strongest performance among the MLLMs across domains. Conclusion: Radiologists generally outperformed MLLMs in categorical tasks, while selected masked models approached human performance for continuous malignancy probability estimation, suggesting a potential adjunctive role.

cs.CV↗

arXiv2026

Ultrasound-based detection and malignancy prediction of breast lesions eligible for biopsy: A multi-center clinical-scenario study using nomograms, large language models, and radiologist evaluation

To develop and externally validate integrated ultrasound nomograms combining BIRADS features and quantitative morphometric characteristics, and to compare their performance with expert radiologists and state of the art large language models in biopsy recommendation and malignancy prediction for breast lesions. In this retrospective multicenter, multinational study, 1747 women with pathologically confirmed breast lesions underwent ultrasound across three centers in Iran and Turkey. A total of 10 BIRADS and 26 morphological features were extracted from each lesion. A BIRADS, morphometric, and fused nomogram integrating both feature sets was constructed via logistic regression. Three radiologists (one senior, two general) and two ChatGPT variants independently interpreted deidentified breast lesion images. Diagnostic performance for biopsy recommendation (BIRADS 4,5) and malignancy prediction was assessed in internal and two external validation cohorts. In pooled analysis, the fused nomogram achieved the highest accuracy for biopsy recommendation (83.0%) and malignancy prediction (83.8%), outperforming the morphometric nomogram, three radiologists and both ChatGPT models. Its AUCs were 0.901 and 0.853 for the two tasks, respectively. In addition, the performance of the BIRADS nomogram was significantly higher than the morphometric nomogram, three radiologists and both ChatGPT models for biopsy recommendation and malignancy prediction. External validation confirmed the robust generalizability across different ultrasound platforms and populations. An integrated BIRADS morphometric nomogram consistently outperforms standalone models, LLMs, and radiologists in guiding biopsy decisions and predicting malignancy. These interpretable, externally validated tools have the potential to reduce unnecessary biopsies and enhance personalized decision making in breast imaging.

eess.IV↗